Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KAT8 | Q9H7Z6 | 1/20 | 0.58 |
| ▸ | GAA | P10253 | 3/20 | 0.57 |
| ▸ | MAPT | P10636 | 1/20 | 0.57 |
| ▸ | GLS | O94925 | 1/20 | 0.55 |
| ▸ | ATM | Q13315 | 1/20 | 0.54 |
| ▸ | RAB9A | P51151 | 2/20 | 0.54 |
| ▸ | POLB | P06746 | 3/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.52 |
| ▸ | NPC1 | O15118 | 1/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.52 |
| ▸ | MEN1 | O00255 | 1/20 | 0.52 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29423653 | 0.91 | RAB9A (0.58) | KAT8GAAMAPTGLSATM | |
| SCHEMBL29423655 | 0.90 | ALDH1A1 (0.63) | GAAMAPTPOLBALDH1A1KMT2A | |
| SCHEMBL20034563 | 0.85 | GLS (0.64) | KAT8GLS | |
| SCHEMBL29353446 | 0.84 | KAT8 (0.61) | KAT8GAAMAPTGLSATM | |
| SCHEMBL29390929 | 0.81 | ALDH1A1 (0.60) | MAPTPOLBALDH1A1 | |
| SCHEMBL8832776 | 0.81 | KAT8 (0.74) | KAT8GAAMAPTGLSPOLB | |
| SCHEMBL14192408 | 0.80 | KAT8 (0.69) | KAT8GAAMAPTGLSATM | |
| SCHEMBL29359926 | 0.79 | ALDH1A1 (0.65) | GAAMAPTRAB9APOLBALDH1A1 | |
| SCHEMBL8282186 | 0.78 | KAT8 (0.65) | KAT8GAAMAPTGLSATM | |
| SCHEMBL12354953 | 0.78 | KAT8 (0.65) | KAT8GAAMAPTGLSATM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 45 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12617905-B2 | Crosslinked alginic acid | MOCHIDA PHARMACEUTICAL CO., LTD. (JP) | 2026-05-05 | — | — | US | claimed |
| US-12490651-B2 | Compound for organic electronic element, organic electronic element using the same, and an electronic device thereof | DUK SAN NEOLUX CO., LTD. (KR) | 2025-12-02 | — | — | US | claimed |
| EP-4620944-A1 | COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT USING SAME, AND ELECTRONIC DEVICE HAVING SAME | Duk San Neolux Co., Ltd. (KR) | 2025-09-24 | — | — | EP | claimed |
| US-20250287833-A1 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF | DUK SAN NEOLUX CO., LTD. (KR) | 2025-09-11 | — | — | US | claimed |
| US-20250268101-A1 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF | DUK SAN NEOLUX CO., LTD. (KR) | 2025-08-21 | — | — | US | claimed |
| WO-2025135627-A1 | COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT USING SAME, AND ELECTRONIC DEVICE THEREOF | 덕산네오룩스 주식회사 | 2025-06-26 | — | — | WO | claimed |
| WO-2025075485-A1 | COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT USING SAME, AND ELECTRONIC DEVICE HAVING SAME | 덕산네오룩스 주식회사 | 2025-04-10 | — | — | WO | claimed |
| CN-118791646-A | Extraction process of edible fungus mycelium polysaccharide | 宁夏农产品质量标准与检测技术研究所(宁夏农产品质量监测中心) | 2024-10-18 | — | — | CN | claimed |
| US-20240316248-A1 | TRANSPLANTATION DEVICE USING CHEMICALLY CROSSLINKED ALGINIC ACID | MOCHIDA PHARMACEUTICAL CO., LTD. (JP) | 2024-09-26 | — | — | US | claimed |
| US-20230035986-A1 | NOVEL CROSSLINKED ALGINIC ACID | MOCHIDA PHARMACEUTICAL CO., LTD. (JP) | 2023-02-02 | — | — | US | claimed |
| EP-4736896-A1 | BIOCOMPATIBLE DEVICE | Mochida Pharmaceutical Co., Ltd. (JP) | 2026-05-06 | — | — | EP | disclosed |
| US-12617905-B2 | Crosslinked alginic acid | MOCHIDA PHARMACEUTICAL CO., LTD. (JP) | 2026-05-05 | — | — | US | disclosed |
| US-12595318-B2 | — | — | 2026-04-07 | — | — | US | disclosed |
| US-12552787-B2 | Quinazoline compound | MEDSHINE DISCOVERY INC. (CN) | 2026-02-17 | — | — | US | disclosed |
| US-20250377301-A1 | STABILISED FLUOROPHORES, COMPOSITIONS, METHODS OF PREPARATION, CONJUGATES THEREOF, AND METHODS OF USE | FREISTAAT BAYERN LUDWIG MAXIMILIANS UNIV MUENCHEN (DE) | 2025-12-11 | — | — | US | disclosed |
| US-20220409773-A1 | TRANSPLANTATION DEVICE USING CHEMICALLY CROSSLINKED ALGINIC ACID | MOCHIDA PHARMACEUTICAL CO., LTD. (JP) | 2022-12-29 | — | — | US | disclosed |
| US-20220348564-A1 | PHENYL-[1,3]DIOXOLO[4,5-C]PYRIDINYL-PHENYL-, PHENYL-[1,3]DIOXOLO[4,5-C]PYRIDINYL-HETEROARYL-, OR PHENYL-(1,3)DIOXO[4,5-C]PYRIDINYL-PIPERIDINYL-METHYL-OXETANYLMETHYL-1H-BENZO[D]IMIDAZOLE-CARBOXYLIC ACID DERIVATIVES AND METHODS OF USING SAME | ECCOGENE (SHANGHAI) CO., LTD. (CN) | 2022-11-03 | — | — | US | disclosed |
| WO-2022199661-A1 | PHENYL- [1, 3] DIOXOLO [4, 5-C] PYRIDINYL-PHENYL-, PHENYL- [1, 3] DIOXOLO [4, 5-C] PYRIDINYL-HETEROARYL-, OR PHENYL- [1, 3] DIOXOLO [4, 5-C] PYRIDINYL-PIPERIDINYL-METHYL-OXETANYLMETHYL-1H-BENZO [D] IMIDAZOLE-CARBOXYLIC ACID DERIVATIVES AND METHODS OF USING SAME | ECCOGENE (SHANGHAI) CO., LTD. (CN) | 2022-09-29 | — | — | WO | disclosed |
| US-20220048852-A1 | PROCESS OF PREPARING IOSIMENOL | OTSUKA PHARMA CO LTD (JP) | 2022-02-17 | — | — | US | disclosed |
| WO-2022017519-A1 | QUINAZOLINE COMPOUND | 南京明德新药研发有限公司 | 2022-01-27 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (9 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250377301-A1 | STABILISED FLUOROPHORES, COMPOSITIONS, METHODS OF PREPARATION, CONJUGATES THEREOF, AND METHODS OF USE | CRY1, MKI67, IK | KAT8 4239/4885GAA 3939/4885MAPT 1613/4885 |
| US-20250287833-A1 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF | NFE2L2, GPX1, ELP1 | KAT8 1165/4885GAA 1785/4885MAPT 1442/4885 |
| US-20250268101-A1 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF | NFE2L2, GPX1, ELP1 | KAT8 1165/4885GAA 1785/4885MAPT 1442/4885 |
| US-12617905-B2 | Crosslinked alginic acid | ALG1, ANXA6, HEXB | KAT8 1747/4885GAA 1517/4885MAPT 3686/4885 |
| US-12552787-B2 | Quinazoline compound | SLC9A3, CLIC1, NHERF1 | KAT8 1668/4885GAA 3546/4885MAPT 4473/4885 |
| US-20220048852-A1 | PROCESS OF PREPARING IOSIMENOL | AOC2, SSTR2, NISCH | KAT8 2421/4885GAA 3556/4885MAPT 4820/4885 |
| US-12595318-B2 | — | ALG1, ALG8, FUCA1 | KAT8 3403/4885GAA 587/4885MAPT 3502/4885 |
| US-12490651-B2 | Compound for organic electronic element, organic electronic element using the same, and an electronic device thereof | NFE2L2, GPX1, ELP1 | KAT8 1165/4885GAA 1785/4885MAPT 1442/4885 |
| US-20220348564-A1 | PHENYL-[1,3]DIOXOLO[4,5-C]PYRIDINYL-PHENYL-, PHENYL-[1,3]DIOXOLO[4,5-C]PYRIDINYL-HETEROARYL-, OR PHENYL-(1,3)DIOXO[4,5-C]PYRIDINYL-PIPERIDINYL-METHYL-OXETANYLMETHYL-1H-BENZO[D]IMIDAZOLE-CARBOXYLIC ACID DERIVATIVES AND METHODS OF USING SAME | GLP1R, GIPR, SLC5A1 | KAT8 3340/4885GAA 1932/4885MAPT 184/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.